ZOMETA® - Hydration Strategies For Tumour-Induced Hypercalcaemia (TIH)

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

ZOMETA dosing and administration for TIH

ZOMETA is the current standard of care for the prevention of skeletal-related events (SREs)

Hydration is key to the success of treating TIH

Because TIH causes severe fluid imbalances, maintaining proper hydration during treatment is critical²
Patients should be assessed before administration of ZOMETA^® to ensure they are properly hydrated¹
Vigorous saline hydration should be employed to bring urine output to approximately 2 L/day³
Overhydration should be avoided in patients at risk for cardiac failure¹

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.